Figure 4From: Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation The graft survival after biopsy of HCV + and HCV- in TG. The median graft survival after biopsy in HCV- group and HCV + was 48 months and 24 months respectively (P = 0.005).Back to article page